Compared with chemotherapy alone, neoadjuvant nivolumab plus chemotherapy extends overall survival in patients with resectable non-small cell lung cancer.

Two women from Phoenix with a common diagnosis in their pasts are set to make history overseas on a dragon boat. Not only is dragon boating considered to be an ancient sport that has made its way into ...

Now, the work presented at the 2025 annual EULAR congress in Barcelona adds two important pieces to the puzzle.

Former President Joe Biden is battling an 'aggressive' form of prostate cancer, which is the second leading cause of cancer ...

Keytruda was approved for locally advanced head and neck cancer before and after surgery, showing improved event-free ...

Incyte today announced that primary results from the Phase 3 POD1UM-303/InterAACT 2 trial of retifanlimab (Zynyz®), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in ...

Regulatory authorities issued precautionary recommendations following the ORAL Surveillance trial, which demonstrated an ...

Teddi Mellencamp recently addressed the criticism she’s faced over her personal life amid her stage 4 cancer battle.

The South Carolina Department of Public Health is reminding South Carolinians to take extra precautions this summer, to help ...

Investigators used the Shiny method, which employs artificial intelligence, to indirectly compare the efficacy of novel systemic therapies for urothelial cancer using phase 3 trial data.

Dr. Michael Serzan provides expert takeaways on treatment updates for patients with early-stage kidney cancer following the 2025 ASCO Meeting.

Even though there is no clarity on why the cases of cancer are not known, according to doctors, the factors that put some ...